Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.

Liu X, Wang J, Chen L.

Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12. Review.

PMID:
23153794
2.

Understanding genomic alterations in cancer genomes using an integrative network approach.

Wang E.

Cancer Lett. 2013 Nov 1;340(2):261-9. doi: 10.1016/j.canlet.2012.11.050. Epub 2012 Dec 22. Review.

PMID:
23266571
3.

Next-generation sequencing in the clinic: promises and challenges.

Xuan J, Yu Y, Qing T, Guo L, Shi L.

Cancer Lett. 2013 Nov 1;340(2):284-95. doi: 10.1016/j.canlet.2012.11.025. Epub 2012 Nov 19. Review.

PMID:
23174106
4.

Cancer omics: from regulatory networks to clinical outcomes.

Tang B, Hsu PY, Huang TH, Jin VX.

Cancer Lett. 2013 Nov 1;340(2):277-83. doi: 10.1016/j.canlet.2012.11.033. Epub 2012 Nov 29. Review.

PMID:
23201140
5.

Comprehensive genome sequencing of the liver cancer genome.

Nakagawa H, Shibata T.

Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Review.

PMID:
23142287
6.

Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.

Li S, Mao M.

Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12. Review.

PMID:
23063663
7.

Sequencing the transcriptional network of androgen receptor in prostate cancer.

Chng KR, Cheung E.

Cancer Lett. 2013 Nov 1;340(2):254-60. doi: 10.1016/j.canlet.2012.11.009. Epub 2012 Nov 27. Review.

PMID:
23196061
8.

Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.

Horswell S, Matthews N, Swanton C.

Cancer Lett. 2013 Nov 1;340(2):220-6. doi: 10.1016/j.canlet.2012.10.031. Epub 2012 Nov 8. Review.

PMID:
23142290
9.

Genomic sequencing in cancer.

Tuna M, Amos CI.

Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23. Review.

10.

Implementing genomic medicine in pathology.

Williams ES, Hegde M.

Adv Anat Pathol. 2013 Jul;20(4):238-44. doi: 10.1097/PAP.0b013e3182977199. Review.

PMID:
23752086
11.

Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.

Feng H, Qin Z, Zhang X.

Cancer Lett. 2013 Nov 1;340(2):179-91. doi: 10.1016/j.canlet.2012.11.010. Epub 2012 Nov 27. Review.

PMID:
23196057
12.

Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.

Patel LR, Nykter M, Chen K, Zhang W.

Cancer Lett. 2013 Nov 1;340(2):152-60. doi: 10.1016/j.canlet.2012.10.018. Epub 2012 Oct 27. Review.

13.

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Roukos DH.

Pharmacogenomics J. 2011 Apr;11(2):81-92. doi: 10.1038/tpj.2010.81. Epub 2010 Oct 26. Review.

PMID:
20975737
14.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
15.

Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer.

Martens-Uzunova ES, Olvedy M, Jenster G.

Cancer Lett. 2013 Nov 1;340(2):201-11. doi: 10.1016/j.canlet.2012.11.058. Epub 2013 Jan 29. Review.

16.

Cancer genomics: technology, discovery, and translation.

Tran B, Dancey JE, Kamel-Reid S, McPherson JD, Bedard PL, Brown AM, Zhang T, Shaw P, Onetto N, Stein L, Hudson TJ, Neel BG, Siu LL.

J Clin Oncol. 2012 Feb 20;30(6):647-60. doi: 10.1200/JCO.2011.39.2316. Epub 2012 Jan 23. Review. Erratum in: J Clin Oncol. 2012 Apr 1;30(10):1149.

PMID:
22271477
17.

Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.

Wang E, Zaman N, Mcgee S, Milanese JS, Masoudi-Nejad A, O'Connor-McCourt M.

Semin Cancer Biol. 2015 Feb;30:4-12. doi: 10.1016/j.semcancer.2014.04.002. Epub 2014 Apr 18. Review.

PMID:
24747696
18.

Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.

Zhang J, Liu J, Sun J, Chen C, Foltz G, Lin B.

Brief Bioinform. 2014 Mar;15(2):244-55. doi: 10.1093/bib/bbt042. Epub 2013 Jul 1. Review.

PMID:
23818492
19.

Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T.

World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284. Review.

20.

Identifying molecular drivers of gastric cancer through next-generation sequencing.

Liang H, Kim YH.

Cancer Lett. 2013 Nov 1;340(2):241-6. doi: 10.1016/j.canlet.2012.11.029. Epub 2012 Nov 20. Review.

Supplemental Content

Support Center